Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955981 · ClinicalTrials.gov registry record · Phase 2
Gout Dose Response Study
A Phase 2 study, sponsored by Ardea Biosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 123
- Enrollment target
NCT00955981 is a Phase 2 study that has completed, run by Ardea Biosciences. The registered enrollment target is 123 participants.
The verdict
NCT00955981, a Phase 2 study, has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 123 participants
- Enrollment target
Study Summary
To compare the proportion of subjects whose serum urate (sUA) level is \< 6.0 mg/dL after 28 days of dosing by treatment group.
Interventions
- DRUG Placebo
- DRUG RDEA594
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00955981
The ClinicalTrials.gov registry entry for NCT00955981 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00955981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00955981 about?
NCT00955981 is a clinical study titled "Gout Dose Response Study". To compare the proportion of subjects whose serum urate (sUA) level is \< 6.0 mg/dL after 28 days of dosing by treatment group.
What is the current status of trial NCT00955981?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 123 participants. The study started on 2009-07. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00955981?
The interventions under investigation include: Placebo (DRUG), RDEA594 (DRUG).
Who is sponsoring clinical trial NCT00955981?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.